Triveni Bio Doses First Healthy Volunteers in Clinical Trial for TRIV-509 | |
Compass' Tovecimig (CTX-009) Meets Primary Endpoint in Phase 2/3 Study | |
Ankyra Announces Expansion of Collaboration with J&J to advance IL-12 Anchored Drug Conjugate | |
Ovation.io and Illumina Collaborate to Advance Genomic Data Research | |
Orbit Discovery and Evergreen Theragnostics Expand Research Collaboration | |
Triveni Bio Raises $115M Series B to Expand Pipeline Addressing I&I Disorders | |
